{
  "name": "Amgen",
  "slug": "amgen",
  "ticker": "AMGN",
  "fetched_at": "2026-02-11T12:44:51.990524+00:00",
  "news": [
    {
      "title": "Prospera Financial Services Inc Sells 6,723 Shares of Amgen Inc. $AMGN - MarketBeat",
      "link": "https://news.google.com/rss/articles/CBMixwFBVV95cUxQX3lwb3NneFZGa28zdUV1dmRGLTcyZVl6NmVFVTFDNW1uQjVSOHhHSmRFQUl2X211YktySjNpU2VHWmNwWGFDNjdvWWU0ZmZIY29BRHFXZVRVS3dUemFfbTFPY3Foem5RbXJiX1U1ZlFoWnVxZzBZWlJQT0dfVkVDbkdCMmdMeDJLVXJzYWg0YmhtdktCUU44ZnExeGxWMkg1VVp0YmpyOGZkTU0xanNNcV9TcTQtNS1UV0dhTk4zTU9BdHB5T09V?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMixwFBVV95cUxQX3lwb3NneFZGa28zdUV1dmRGLTcyZVl6NmVFVTFDNW1uQjVSOHhHSmRFQUl2X211YktySjNpU2VHWmNwWGFDNjdvWWU0ZmZIY29BRHFXZVRVS3dUemFfbTFPY3Foem5RbXJiX1U1ZlFoWnVxZzBZWlJQT0dfVkVDbkdCMmdMeDJLVXJzYWg0YmhtdktCUU44ZnExeGxWMkg1VVp0YmpyOGZkTU0xanNNcV9TcTQtNS1UV0dhTk4zTU9BdHB5T09V?oc=5\" target=\"_blank\">Prospera Financial Services Inc Sells 6,723 Shares of Amgen Inc. $AMGN</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MarketBeat</font>",
      "published": "2026-02-11T11:44:47+00:00",
      "source": "MarketBeat"
    },
    {
      "title": "Highlights from Amgen's 2025 Fourth Quarter and Full Year Earnings Report - Amgen",
      "link": "https://news.google.com/rss/articles/CBMirwFBVV95cUxNa1A1XzhsX21GQmMxVWNQQWlKSmFsN0d2Zk1saTI4al9sZW1WODJmMFZpMWpRQ1QzbE1qSjZieTU4WEFMblBSeEQxekZjSkZFQm00MmNnVnNhTmlpdmgzYVF3emZBZmptQ2dJVGJnWlh1NFE5TlFreE80SWxjdF8tSUp5enRVenFBMVZrc2lfbnRFLXJDaUV6SzlrcVU1M292TW9kVlFsajBmU0lhdElR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMirwFBVV95cUxNa1A1XzhsX21GQmMxVWNQQWlKSmFsN0d2Zk1saTI4al9sZW1WODJmMFZpMWpRQ1QzbE1qSjZieTU4WEFMblBSeEQxekZjSkZFQm00MmNnVnNhTmlpdmgzYVF3emZBZmptQ2dJVGJnWlh1NFE5TlFreE80SWxjdF8tSUp5enRVenFBMVZrc2lfbnRFLXJDaUV6SzlrcVU1M292TW9kVlFsajBmU0lhdElR?oc=5\" target=\"_blank\">Highlights from Amgen's 2025 Fourth Quarter and Full Year Earnings Report</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Amgen</font>",
      "published": "2026-02-03T21:35:04+00:00",
      "source": "Amgen"
    },
    {
      "title": "CVS Health to drop Amgen and Lilly's bone disease treatments from some drug lists - Reuters",
      "link": "https://news.google.com/rss/articles/CBMi1wFBVV95cUxONHNpNEJGdnZtSjZXNGk4UTFSNmowY1lZUVBnNTduYXlNNFBKZDhWYlYzbm9GaWtIdGJhZnl0S0tpSEdRaTBMMmUySXdEWjBzTUFiQ0xKcEFsWExVTHUtWWhsU2NLVFJ2ei1mVkoxQWRFWGVfNy0wRmpSVWtadkJvWnRSdTZqOE9QOXZMamJYWkN5WG4xZDg0bGlBZGpQMjh5M1VnaXd2VXBOV0MxZERPMjhpbXN3N1c4RkdyVFc5M3hELUtTV0Jhd2ZBUjdEMUhLa2V4blpfdw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi1wFBVV95cUxONHNpNEJGdnZtSjZXNGk4UTFSNmowY1lZUVBnNTduYXlNNFBKZDhWYlYzbm9GaWtIdGJhZnl0S0tpSEdRaTBMMmUySXdEWjBzTUFiQ0xKcEFsWExVTHUtWWhsU2NLVFJ2ei1mVkoxQWRFWGVfNy0wRmpSVWtadkJvWnRSdTZqOE9QOXZMamJYWkN5WG4xZDg0bGlBZGpQMjh5M1VnaXd2VXBOV0MxZERPMjhpbXN3N1c4RkdyVFc5M3hELUtTV0Jhd2ZBUjdEMUhLa2V4blpfdw?oc=5\" target=\"_blank\">CVS Health to drop Amgen and Lilly's bone disease treatments from some drug lists</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>",
      "published": "2026-02-05T16:59:56+00:00",
      "source": "Reuters"
    },
    {
      "title": "AMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS - PR Newswire",
      "link": "https://news.google.com/rss/articles/CBMivgFBVV95cUxPbGlPdTREbHB3UXJRZlFydG9zTGQyMnlkeTcwNmpGaTlQdnhiTDJXN1A5SG9VR2R2VWx1cGVpVmJneU9VVzhwVUo1NFc5REswbXV2S2x5cWxrd2dKV19nOTFmNGlERnhTRXhFMVNmWUhVVll0WEFjR2hSajR4T252LXlSTk9rbFhfMHM1NEJiRVFPVHZReUNQbzNKVWZKbTZOV1haQkZNNFZibHZueVRkMHoxLURNVG04bWZ4dllB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivgFBVV95cUxPbGlPdTREbHB3UXJRZlFydG9zTGQyMnlkeTcwNmpGaTlQdnhiTDJXN1A5SG9VR2R2VWx1cGVpVmJneU9VVzhwVUo1NFc5REswbXV2S2x5cWxrd2dKV19nOTFmNGlERnhTRXhFMVNmWUhVVll0WEFjR2hSajR4T252LXlSTk9rbFhfMHM1NEJiRVFPVHZReUNQbzNKVWZKbTZOV1haQkZNNFZibHZueVRkMHoxLURNVG04bWZ4dllB?oc=5\" target=\"_blank\">AMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">PR Newswire</font>",
      "published": "2026-02-03T21:01:00+00:00",
      "source": "PR Newswire"
    },
    {
      "title": "Just Two Days Till Amgen Inc. (NASDAQ:AMGN) Will Be Trading Ex-Dividend - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMiekFVX3lxTE5zeTJybl9jdS1rQjdNTXRyaWtWWG9lc2VqMWloNVB1SjdHZndPdVo2OGtVX1ROUFQyY1RMRW13QXV2c1VJSGs5MHhudzJGaGdMTzR5V2lCSW1QdHBMalRUZWs1dDVkU0huYXN1aUZMUHVwR21Sdzc1V1FB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiekFVX3lxTE5zeTJybl9jdS1rQjdNTXRyaWtWWG9lc2VqMWloNVB1SjdHZndPdVo2OGtVX1ROUFQyY1RMRW13QXV2c1VJSGs5MHhudzJGaGdMTzR5V2lCSW1QdHBMalRUZWs1dDVkU0huYXN1aUZMUHVwR21Sdzc1V1FB?oc=5\" target=\"_blank\">Just Two Days Till Amgen Inc. (NASDAQ:AMGN) Will Be Trading Ex-Dividend</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2026-02-10T13:15:56+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Amgen, Merck share losses contribute to Dow's 200-point drop - MSN",
      "link": "https://news.google.com/rss/articles/CBMisAFBVV95cUxNWmpyMVIxNWdBblduakVWQXlUSmVrcG45MXFObXdTR0JfNHUyUUJGckx5dzFvOTZKWm50QWU5ZUppRkJpamFOd1huT0lrc1BDbWNVLVlORXRianBnU3FyNjM4cmRjRlRmYUk3U0UyWUl3MTMwM2pZV3RkekV1TVFrcnlnN0M3WHBwUUxod1N1T1NGcThmMi14SFg5ZExaRUV2TDFKYS1DNUZMaEpqNGw4dg?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMisAFBVV95cUxNWmpyMVIxNWdBblduakVWQXlUSmVrcG45MXFObXdTR0JfNHUyUUJGckx5dzFvOTZKWm50QWU5ZUppRkJpamFOd1huT0lrc1BDbWNVLVlORXRianBnU3FyNjM4cmRjRlRmYUk3U0UyWUl3MTMwM2pZV3RkekV1TVFrcnlnN0M3WHBwUUxod1N1T1NGcThmMi14SFg5ZExaRUV2TDFKYS1DNUZMaEpqNGw4dg?oc=5\" target=\"_blank\">Amgen, Merck share losses contribute to Dow's 200-point drop</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MSN</font>",
      "published": "2026-02-09T15:30:05+00:00",
      "source": "MSN"
    },
    {
      "title": "AstraZeneca Unit Settles Soliris Feud With Samsung, Amgen - Law360",
      "link": "https://news.google.com/rss/articles/CBMinAFBVV95cUxNNmNIblMzS3phakQ1cXZBSE15Nzl5dERxUDdSYS1aVTZtZmxMekN6TWhZUXJwNk9YaVRvS044Q2lYNm5jNlFlanJMRy1xcGpIdFptdVF3anlEZ1g4N1dQTDItNEljWmxFdnFuV2M1TXdlZFpMRHhHempjYnFWVEE3MWVRb2hoMGdGT2RFaFFkMS12Z3NYd0QxaGRPckLSAVZBVV95cUxNNTJVc3ZKX1ZKQVI4NS04OERkNW9oUjBYbTFtSHlSLWxZd3NSZ1V3ME5jU0hlNkpHZjV0X3g3WmNyWGZqVzNuWHh6QndSbDNINjFEcWZHQQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMinAFBVV95cUxNNmNIblMzS3phakQ1cXZBSE15Nzl5dERxUDdSYS1aVTZtZmxMekN6TWhZUXJwNk9YaVRvS044Q2lYNm5jNlFlanJMRy1xcGpIdFptdVF3anlEZ1g4N1dQTDItNEljWmxFdnFuV2M1TXdlZFpMRHhHempjYnFWVEE3MWVRb2hoMGdGT2RFaFFkMS12Z3NYd0QxaGRPckLSAVZBVV95cUxNNTJVc3ZKX1ZKQVI4NS04OERkNW9oUjBYbTFtSHlSLWxZd3NSZ1V3ME5jU0hlNkpHZjV0X3g3WmNyWGZqVzNuWHh6QndSbDNINjFEcWZHQQ?oc=5\" target=\"_blank\">AstraZeneca Unit Settles Soliris Feud With Samsung, Amgen</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Law360</font>",
      "published": "2026-02-10T18:40:00+00:00",
      "source": "Law360"
    },
    {
      "title": "Fierce Pharma Asia—Amgen, Kyowa's OX40 divorce; Roche's RNAi deal; Daiichi's ADC cull - Fierce Pharma",
      "link": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPZmhFMXhES2VlNXoxdzduZ2pSVkNiRHZmbHZ5R2xGbk9BNDFUZW9vWlNIUTFXUm1zV0JiRkZsa19FbjhOMDhaaXU3aDBsZUp1VU1rRm5JLXVmTjl1YnpvVVFJd2NPaXY1UUFZNEhFT2M4c2hWb1FCZkJKSUVhQUhYLW1RSUs5ZEdzVHFGUnpJUVZ3V1VWb19LTw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimAFBVV95cUxPZmhFMXhES2VlNXoxdzduZ2pSVkNiRHZmbHZ5R2xGbk9BNDFUZW9vWlNIUTFXUm1zV0JiRkZsa19FbjhOMDhaaXU3aDBsZUp1VU1rRm5JLXVmTjl1YnpvVVFJd2NPaXY1UUFZNEhFT2M4c2hWb1FCZkJKSUVhQUhYLW1RSUs5ZEdzVHFGUnpJUVZ3V1VWb19LTw?oc=5\" target=\"_blank\">Fierce Pharma Asia—Amgen, Kyowa's OX40 divorce; Roche's RNAi deal; Daiichi's ADC cull</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Pharma</font>",
      "published": "2026-02-06T14:48:00+00:00",
      "source": "Fierce Pharma"
    }
  ],
  "product_launches": [
    {
      "title": "Amgen: Solid New-Product Uptake Offset by Legacy Erosion and Execution Risks, Warranting a Hold Rating - TipRanks",
      "link": "https://news.google.com/rss/articles/CBMi3wFBVV95cUxNOGRMMXF5YlJsZk83RlJqN3ozY1VjSUlkYnpXX05zZmZCWnRoRHNrTk9IdGVYczVZVk9WTkw0MjNKYmkySWZXOUdDdGFXZWRrRjR6U0VSbmtJbkx6NkQ1bkQycGxEWDlZRVdSTzJidFBabTZLOWxkWnI0WktQMXRNX1lCS04xMmFhV3lrV1BDbGRmRlVhSnBfV1BaMmoyc3hTV3lZOTBRX08tRnRuX0hKTkplc05sN1Q2enYxSDE4X2ZkcFVVU1lENks1VUJHWFZzY2tfOUIxaFBEa1dnRkQw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi3wFBVV95cUxNOGRMMXF5YlJsZk83RlJqN3ozY1VjSUlkYnpXX05zZmZCWnRoRHNrTk9IdGVYczVZVk9WTkw0MjNKYmkySWZXOUdDdGFXZWRrRjR6U0VSbmtJbkx6NkQ1bkQycGxEWDlZRVdSTzJidFBabTZLOWxkWnI0WktQMXRNX1lCS04xMmFhV3lrV1BDbGRmRlVhSnBfV1BaMmoyc3hTV3lZOTBRX08tRnRuX0hKTkplc05sN1Q2enYxSDE4X2ZkcFVVU1lENks1VUJHWFZzY2tfOUIxaFBEa1dnRkQw?oc=5\" target=\"_blank\">Amgen: Solid New-Product Uptake Offset by Legacy Erosion and Execution Risks, Warranting a Hold Rating</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TipRanks</font>",
      "published": "2026-02-04T03:18:16+00:00",
      "source": "TipRanks"
    },
    {
      "title": "Amgen, Kyowa Kirin Bolster Safety Profile for Atopic Dermatitis Hopeful - BioSpace",
      "link": "https://news.google.com/rss/articles/CBMisgFBVV95cUxQVEJYNkQ0cURCVTNSd1VIbU1JLWtmblBqXzNDZnp6SVBBcWpGcm5zNWdaUFZwdjN4aGR4TnJoYm9PMWk2STRNdmdKMjRKU2pQVURtamRpUDBja3ZhYk1ONHJRemdtdkpVRHJ3SXBESkdyNG1hMW1ZQW4wb0xpYmMxY0E5RkRyVERkaS1FczJlUmZmbVZRN2VWenB5czdkeFg4eG5jNkZqQm9RU3FaMjl6dl9R?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMisgFBVV95cUxQVEJYNkQ0cURCVTNSd1VIbU1JLWtmblBqXzNDZnp6SVBBcWpGcm5zNWdaUFZwdjN4aGR4TnJoYm9PMWk2STRNdmdKMjRKU2pQVURtamRpUDBja3ZhYk1ONHJRemdtdkpVRHJ3SXBESkdyNG1hMW1ZQW4wb0xpYmMxY0E5RkRyVERkaS1FczJlUmZmbVZRN2VWenB5czdkeFg4eG5jNkZqQm9RU3FaMjl6dl9R?oc=5\" target=\"_blank\">Amgen, Kyowa Kirin Bolster Safety Profile for Atopic Dermatitis Hopeful</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioSpace</font>",
      "published": "2025-09-10T07:00:00+00:00",
      "source": "BioSpace"
    },
    {
      "title": "A Look at Amgen’s (AMGN) Valuation as Repatha Scores Major Trial Win and Direct Sales Launch Spurs Optimism - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMihgFBVV95cUxObWpGcHFxUm1WbnhhdFJUOW1kcjlGamhOQTdxdnVqWVRmQkxzNzdYd0poQk96QVByUENRMHhxQlFhVXctWGhjSWw4bjIzMXoxdFhLaVhpU0xMbnltTjhBejY4X1lQOWJuRENDNjVTbWxRRjZMMERRT0RVLVdETjhUcVljeTM3QQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMihgFBVV95cUxObWpGcHFxUm1WbnhhdFJUOW1kcjlGamhOQTdxdnVqWVRmQkxzNzdYd0poQk96QVByUENRMHhxQlFhVXctWGhjSWw4bjIzMXoxdFhLaVhpU0xMbnltTjhBejY4X1lQOWJuRENDNjVTbWxRRjZMMERRT0RVLVdETjhUcVljeTM3QQ?oc=5\" target=\"_blank\">A Look at Amgen’s (AMGN) Valuation as Repatha Scores Major Trial Win and Direct Sales Launch Spurs Optimism</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-10-16T07:00:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "3 major patent losses this year — and a key strategy to fill the gaps - PharmaVoice",
      "link": "https://news.google.com/rss/articles/CBMimgFBVV95cUxPNGpDZTgwdDRLOFozTU9HVGVzWWpkS1dXSEd4X1c0RzVVdktmbzUwVVhWSW01X3BkbGl5c084anVWeHVkX1FEU1pEMm13ZW91WlBwNE5CQVVmYURaaEFOREx0dk1fTTJyT01lYW1ZVXBOV2ZXTTdFamNYc2FVbTAyazJOeEVnNkszUXphcjI5blNXSV9wZ0tmcThR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimgFBVV95cUxPNGpDZTgwdDRLOFozTU9HVGVzWWpkS1dXSEd4X1c0RzVVdktmbzUwVVhWSW01X3BkbGl5c084anVWeHVkX1FEU1pEMm13ZW91WlBwNE5CQVVmYURaaEFOREx0dk1fTTJyT01lYW1ZVXBOV2ZXTTdFamNYc2FVbTAyazJOeEVnNkszUXphcjI5blNXSV9wZ0tmcThR?oc=5\" target=\"_blank\">3 major patent losses this year — and a key strategy to fill the gaps</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">PharmaVoice</font>",
      "published": "2025-07-21T07:00:00+00:00",
      "source": "PharmaVoice"
    },
    {
      "title": "Amgen: Biosimilars And Rare Disease Pipeline Crucial To Overcome Patent Cliff Concerns - Seeking Alpha",
      "link": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNNldFcDdyVUNrRFhsN2JMUDZuakRJNDN5R0JBNzFfbXNuaGVLVTRubVhsV3l2eEk4MGR2X2xLcXVON3NHVVZOVjZvZHNzdHBsTGVNZEFJaEp2WGRxUnNYdng4TS1yaWNrd1g5bW5tcnNvZUh1QzlleW96akRZUG1tNGRKLXdqdmg5TUdudlpielVzcHd2VUpYa3pfWkJjX0lESEJDc3BET1hFWGtreWdqNEdkNlMtT2dncThfMVVuOA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivwFBVV95cUxNNldFcDdyVUNrRFhsN2JMUDZuakRJNDN5R0JBNzFfbXNuaGVLVTRubVhsV3l2eEk4MGR2X2xLcXVON3NHVVZOVjZvZHNzdHBsTGVNZEFJaEp2WGRxUnNYdng4TS1yaWNrd1g5bW5tcnNvZUh1QzlleW96akRZUG1tNGRKLXdqdmg5TUdudlpielVzcHd2VUpYa3pfWkJjX0lESEJDc3BET1hFWGtreWdqNEdkNlMtT2dncThfMVVuOA?oc=5\" target=\"_blank\">Amgen: Biosimilars And Rare Disease Pipeline Crucial To Overcome Patent Cliff Concerns</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
      "published": "2025-07-15T07:00:00+00:00",
      "source": "Seeking Alpha"
    }
  ],
  "stock": {
    "ticker": "AMGN",
    "currency": "USD",
    "latest": {
      "date": "2026-02-10",
      "close": 364.6499938964844
    },
    "history": [
      {
        "date": "2026-02-02",
        "close": 344.67999267578125
      },
      {
        "date": "2026-02-03",
        "close": 338.5899963378906
      },
      {
        "date": "2026-02-04",
        "close": 366.20001220703125
      },
      {
        "date": "2026-02-05",
        "close": 367.79998779296875
      },
      {
        "date": "2026-02-06",
        "close": 384.32000732421875
      },
      {
        "date": "2026-02-09",
        "close": 375.82000732421875
      },
      {
        "date": "2026-02-10",
        "close": 364.6499938964844
      }
    ],
    "name": "Amgen Inc."
  }
}